Barry Selick Moves From UCSF To Hinge Bio

Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive, and entrepreneur, appointed Chief Executive Officer at Hinge Bio.

“The opportunity to create novel technologies that can be translated into therapeutics that improve patients’ lives has motivated my entire career,” said Dr. Selick. “The unique GEM-DIMER platform’s wide range of addressable therapeutic indications and its ability to engage multiple target molecules in a novel manner enables broad opportunities in drug development for improved therapies against validated targets as well as first-in-class options for novel ones. The team has made remarkable progress so far in demonstrating the technical potential of the platform and I am excited to join them as we advance Hinge Bio’s programs toward product candidate selection and clinical development with an initial focus on therapeutics that will benefit patients living with cancer.”